Tag: #M&A

Biopharmaceutical giant AbbVie has announced a definitive agreement to acquire a device manufacturing facility in Tempe, Arizona, along with associated... Read more

The global pharmaceutical market is abuzz with reports that Merck & Co. (MSD) is in active negotiations to acquire Revolution... Read more

U.S. biotech giant Amgen has agreed to acquire Oxford-based Dark Blue Therapeutics in a deal valued at up to $840... Read more

On January 8, 2026, Day One Biopharmaceuticals announced the formal completion of its acquisition of Mersana Therapeutics following the satisfaction... Read more

Eli Lilly has officially announced an agreement to acquire Ventyx Biosciences for $14 per share, totaling $1.2 billion. This strategic... Read more

Expanding Oncology Portfolio with Breakthrough Science On December 30, 2025, Johnson & Johnson (J&J) announced the completion of its acquisition... Read more

Strengthening adult immunization strategic assets The French pharmaceutical giant Sanofi has reached a definitive agreement to acquire Dynavax Technologies for... Read more

Strategic takeover deal ahead of the holidays French pharmaceutical giant Sanofi has reached an agreement to acquire Dynavax, a California-based... Read more

AstraZeneca has officially entered into a global licensing agreement worth up to $2 billion for Jacobio Pharma’s Pan-KRAS inhibitor candidate,... Read more